Professor Adrian Hayday
Kings College London
Adrian Hayday trained in biochemistry (Cambridge) and then molecular virology (London). At MIT in 1985, he and his colleagues discovered the T cell receptor gamma chain genes, an wholly unanticipated component of the immune system, that he has since shown to be unique by many criteria. His demonstration that gamma delta T cell deficiency is associated with profound susceptibility to skin carcinogens (Science, 2001) was instrumental in promoting his and others’ commitment to the cells’ clinical application for immunotherapy. Recently, Professor Hayday has pioneered studies of human immune responses to vaccination and cancer, and also leads a Wellcome Trust-supported, multi-centre, high-throughput screen that provides to the community open-access information about novel genetic regulators of the immune system. Professor Hayday has over 200 papers, of which he is first, last, or corresponding author on over 120, and of which 150 describe original research. Among many awards, he received the William Clyde deVane Medal, Yale College’s highest honour for scholarship and teaching; an honorary fellowship of King’s College London; the UK Business of Science Award, 2017. He was elected to lead the British Society of Immunology (2005-09) and is an elected fellow of the Academy of Medical Sciences and the Royal Society.